Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Nappi

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|December 25, 2018
Loss of Nuclear Functions of HOXA10 Is Associated With Testicular Cancer ProliferationRuiqi Chen, Haolong Li, Yinan Li, et al.
Future Oncology (London, England)|June 30, 2018
Clinical features and psychological aspects of the decision-making process in stage I testicular germ cell tumorsCaterina Condello, Pasquale Rescigno, Margaret Ottaviano, et al.
World Journal of Clinical Oncology|July 13, 2012
Everolimus plus long-acting somatostatin analogs in thymic epithelial malignanciesGiovannella Palmieri, Carlo Buonerba, Piera Federico, et al.
Clinical Genitourinary Cancer|June 22, 2016
Molecular Dissection of Complete Response to Receptor Tyrosine Kinase Inhibition in Type II Papillary Renal Cell CarcinomaMatti Annala, Lucia Nappi, Arun A Azad, et al.
Oncoimmunology|October 2, 2013
Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinomaRoberta Rosa, Vincenzo Damiano, Luigi Formisano, et al.
Oncotarget|May 17, 2018
Long term deficiency of vitamin D in germ cell testicular cancer survivorsLucia Nappi, Margaret Ottaviano, Pasquale Rescigno, et al.
JCO Oncology Practice|January 26, 2024
Once Upon a Time…. Simple, Sensible Management of Venous Access for Chemotherapy Delivery in Germ Cell TumorsGuliz Ozgun, LaTrice Haney, Sean Kern, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 5, 2025
Key Updates in Testicular Cancer: Optimizing Survivorship and SurvivalAditya Bagrodia, Hege Sagstuen Haugnes, Ragnhild Hellesnes, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trialsChiara Carlomagno, Gennaro Daniele, Roberto Bianco, et al.
Molecular Cancer Therapeutics|March 6, 2015
Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and ChemotherapyBarbara Lelj-Garolla, Masafumi Kumano, Eliana Beraldi, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|December 25, 2018
Loss of Nuclear Functions of HOXA10 Is Associated With Testicular Cancer ProliferationRuiqi Chen, Haolong Li, Yinan Li, et al.
Future Oncology (London, England)|June 30, 2018
Clinical features and psychological aspects of the decision-making process in stage I testicular germ cell tumorsCaterina Condello, Pasquale Rescigno, Margaret Ottaviano, et al.
World Journal of Clinical Oncology|July 13, 2012
Everolimus plus long-acting somatostatin analogs in thymic epithelial malignanciesGiovannella Palmieri, Carlo Buonerba, Piera Federico, et al.
Clinical Genitourinary Cancer|June 22, 2016
Molecular Dissection of Complete Response to Receptor Tyrosine Kinase Inhibition in Type II Papillary Renal Cell CarcinomaMatti Annala, Lucia Nappi, Arun A Azad, et al.
Oncoimmunology|October 2, 2013
Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinomaRoberta Rosa, Vincenzo Damiano, Luigi Formisano, et al.
Oncotarget|May 17, 2018
Long term deficiency of vitamin D in germ cell testicular cancer survivorsLucia Nappi, Margaret Ottaviano, Pasquale Rescigno, et al.
JCO Oncology Practice|January 26, 2024
Once Upon a Time…. Simple, Sensible Management of Venous Access for Chemotherapy Delivery in Germ Cell TumorsGuliz Ozgun, LaTrice Haney, Sean Kern, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 5, 2025
Key Updates in Testicular Cancer: Optimizing Survivorship and SurvivalAditya Bagrodia, Hege Sagstuen Haugnes, Ragnhild Hellesnes, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trialsChiara Carlomagno, Gennaro Daniele, Roberto Bianco, et al.
Molecular Cancer Therapeutics|March 6, 2015
Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and ChemotherapyBarbara Lelj-Garolla, Masafumi Kumano, Eliana Beraldi, et al.
Pageof 7